--- title: "NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines" ocid: "ocds-r6ebe6-0000796255" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000796255" markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000796255.md" json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000796255.json" source: "Public Contracts Scotland" current_stage: "Award" buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (\"THE AUTHORITY\")" published: "2026-01-06" --- # NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("THE AUTHORITY") Current stage: Award OCID: ocds-r6ebe6-0000796255 [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000796255) [Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000796255.json) ## Summary ```html The Common Services Agency, better known as NHS National Services Scotland, is inviting tenders for a framework agreement titled "NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines". This procurement process, categorised under the health industry, is active and follows an open procedure method. It is divided into 20 lots, concerning the supply of various medicines to NHS Scotland. Based in Edinburgh, the organisation has set 8th September 2025 for the conclusion of the tender period and initiation of the award period. This opportunity involves deliveries across NHS entities throughout the UK, with a significant framework value of approximately £52,999,636 GBP. This tender presents considerable growth prospects for businesses engaged in the production and distribution of medical goods, particularly those licensed to supply medicines in the UK. Companies capable of demonstrating compliance with UK regulations and holding certifications like BS EN ISO 9001 are well-suited to compete. The framework aims for multi-supplier agreements in many categories, offering opportunities even for smaller enterprises to engage successfully. Additionally, the project focuses on community benefits, encouraging suppliers to contribute positively to local communities, potentially enhancing their market position while supporting societal goals. ``` ## Notice This Framework Agreement is for the supply of Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines to health boards across NHS Scotland. The Goods have been split into twenty (20) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice. ### Lot Information Lot 1 - Baclofen Intrathecal Injections Supply of Baclofen Intrathecal Injections to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single Framework Participant. Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 2 - Oxycodone Injections The Supply of Oxycodone Injections to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single Framework Participant. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 3 - Levobupivacaine (As Hydrochloride) Sterile Wrapped Ampoules For Injection The Supply of Levobupivacaine (As Hydrochloride) Sterile Wrapped Ampoules For Injection to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single Framework Participant. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 4 - Oxycodone Hydrochloride Prolonged Release Tablets The Supply of Oxycodone Hydrochloride Prolonged Release Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 5 - Buprenorphine Patches The supply of Buprenorphine Patches to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 6 - Fentanyl Tablets (Sublingual) The Supply of Fentanyl Tablets (Sublingual) to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 7 - Fentanyl Sf Tablet (Buccal) Supply of Fentanyl Sf Tablets(Buccal) to NHS Scotland in a range of presentations. The Authority has not awarded this Lot. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 8 - Fentanyl Transdermal Patch Supply of Fentanyl Transdermal Patch to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 9 - Hydromorphone Supply of Hydromorphone Capsules and Injection to NHS Scotland in a range of presentations. The Authority has awarded each product line within this lot to a single Framework Participant. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 10 - Lidocaine Chlorhexidine Gel Supply of Lidocaine Chlorhexidine Gel to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 11 - Morphine Sulfate Modified-Release capsule (12Hr) Supply of Morphine Sulfate Modified-Release capsule (12hr) to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single Framework Participant. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 12 - Morphine Sulfate Modified-Release capsule (24Hr) The Supply of Morphine Sulfate Modified-Release capsule (24Hr) to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single Framework Participant. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 13 - Morphine Sulfate Modified-Release Tablet The Supply of Morphine Sulfate Modified-Release Tablet to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 14 - Oxycodone Hydrochloride Capsules The Supply of Oxycodone Hydrochloride Capsules to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 15 - Propofol Injection The Supply of Propofol Injection to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 16 - Tramadol Hydrochloride Modified Release Tablets The Supply of Tramadol Hydrochloride Modified Release Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 17 - Oxycodone Oral Solution The Supply of Oxycodone Oral Solution to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 18 - Levobupivacaine (As Hydrochloride) Solution For Infusion The Supply of Levobupivacaine (As Hydrochloride) Solution For Infusion to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 19 - Supply to NHSS Pharmaceuticals "Specials" Service The supply of a range of Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines to the NHSS Pharmaceuticals "Specials" Service. The Authority has awarded each product line within this Lot to a single Framework Participant. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 20 - Levobupivacaine Solution for injection ampoules (unwrapped) Supply of Levobupivacaine solution for injection ampoules (unwrapped) all other Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines in a range of presentations. The Authority has awarded each product line within this Lot to a single Framework Participant. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 21 - All other Analgesics and Anaesthetic Generic Medicines Supply of all other Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines in a range of presentations. The Authority has awarded each product line within this Lot to a single Framework Participant. Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. ## Key Details | Field | Value | | --- | --- | | Publication source | Public Contracts Scotland | | Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JAN546536 | | Notice type | OJEU - F3 - Contract Award Notice | | Procurement type | Framework | | Procurement category | Goods | | Procurement method | Open | | Procurement method details | Open procedure | | Tender suitability | Not specified | | Awardee scale | SME | | All stages | Tender, Award | ## Dates | Field | Value | | --- | --- | | Publication date | 6 Jan 2026 | | Submission deadline | 8 Sep 2025 | | Future notice date | Not specified | | Award date | 12 Dec 2025 | | Contract period | Not specified | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | £52,999,636 | | Lots value | £52,999,636 | | Awards value | Not specified | | Contracts value | £22,471,323 | ## Status | Field | Value | | --- | --- | | Tender status | Complete | | Lots status | Complete | | Awards status | Unsuccessful | | Contracts status | Active | ## Buyer | Field | Value | | --- | --- | | Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("THE AUTHORITY") | | Locality | EDINBURGH | | Post town | Edinburgh | | Postcode | EH12 9EB | | Country | Scotland | | ITL 1 | TLM Scotland | | ITL 2 | TLM1 East Central Scotland | | ITL 3 | TLM13 City of Edinburgh | | Local authority | City of Edinburgh | | Electoral ward | Drum Brae/Gyle | | Westminster constituency | Edinburgh South West | | Delivery location | TLM Scotland | ## Supplier | Field | Value | | --- | --- | | Number of suppliers | 45 | | Supplier names | ACCORD HEALTHCARE; ACCORD-UK; AGUETTANT; ARCADIA PHARMA LIMITED T/A ARCADIA MEDICAL; ASPEN HEALTHCARE SOLUTIONS; ASPIRE PHARMA; B BRAUN MEDICAL; BAXTER HEALTHCARE; BOWMED IBISQUS; CHIESI; CLINIMED; DRUGSRUS; ENNOGEN HEALTHCARE INTERNATIONAL; FRESENIUS KABI; GEROT LANNACH; GLAXOSMITHKLINE; GLENMARK PHARMACEUTICALS EUROPE; HAMELN PHARMA; HIKMA PHARMACEUTICALS; INTRAPHARM LABORATORIES; KENT PHARMACEUTICALS; KYOWA KIRIN INTERNATIONAL NEWCO; MARTINDALE PHARMA; MEDREICH; MERCURY PHARMACEUTICALS; MORNINGSIDE PHARMACEUTICALS; NAPP PHARMACEUTICALS; NEON HEALTHCARE; NOVUMGEN; OPTIMUM MEDICAL; PANPHARMA; PFIZER; PHOENIX LABS; PIRAMAL CRITICAL CARE; QDEM PHARMACEUTICALS; RIDGE PHARMA; SANDOZ; STADA UK - THORNTON & ROSS; SVP PHARMA; TEVA; TORBAY PHARMA; TYPHARM; VIATRIS UK HEALTHCARE; WOCKHARDT; ZENTIVA | ## CPV Codes ### Divisions - 33 - Medical equipments, pharmaceuticals and personal care products ### Codes - 33600000 - Pharmaceutical products ## Release History - 6 Jan 2026 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JAN546536 - 6 Aug 2025 at 00:00 - Tender - OJEU - F2 - Contract Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG536383 ## Documents - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG536383 NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines - This Framework Agreement is for the supply of Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines to health boards across NHS Scotland. The Goods have been split into twenty (20) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice. - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JAN546536 NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines - This Framework Agreement is for the supply of Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines to health boards across NHS Scotland. The Goods have been split into twenty (20) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice. ## Notice URLs - http:// - http://www.nhsscotlandprocurement.scot.nhs.uk/ - https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000796255 - https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000796255. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000796255.json.